|
The eyes are the windows to profit for Bausch & Lomb. Operating as Bausch + Lomb, the eye care company is best known as a leading maker of contact lenses and lens care solutions (including the PureVision and ReNu brands). Along with its contact lens products, Bausch + Lomb makes prescription ophthalmic drugs Alrex, Lotemax, and Zylet. It also makes over-the-counter vitamins and drops through its pharmaceuticals division. Its surgical unit makes instruments and equipment for cataract, vitreoretinal, and other ophthalmic surgeries. Bausch + Lomb markets its products in more than 100 countries worldwide. The company is owned by private equity firm Warburg Pincus, which filed for it to go public in 2013.
|
| | | Contact Information | |
Address: |
1 Bausch & Lomb Place
Rochester, NY 14604-2701
| | Phone: | 585-338-6000 | | Fax: | 585-338-6007 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2012): | 3037.60 M | | Revenue Growth (1 yr): | 6.80% | | Employees (2012): | 11,200 |
|
|
Key People
| | • |
Chairman:
Fred Hassan
| | • |
CEO:
Brent L. Saunders
| | • |
President and CFO:
Robert J. Bertolini
|
|
|
Industry Information
| |
Sector: | |
Industry: |
|
|
